Hyperactive signaling pathways of some aggressive blood cancer cells can be tamped down by a previously unrecognized protein ...

Dr. Ashkan Emadi, principal investigator of a first-in-world phase 2 clinical trial evaluating subcutaneous Blincyto ...

Acute myeloid leukemia (AML) is an aggressive form of blood cancer. It affects people of all ages but is most common in those over 65. Around 150 people are diagnosed with the disease each year in ...

In a new study published in Nature Communications, a research team at the University of Oslo have examined how cancer cells ...

Patients with acute leukemia prioritize tiredness as the most important health dimension over cognition, differing from the general public's preferences. Informal caregivers report significant ...

The diagnosis of acute leukaemia in children, most notably acute lymphoblastic leukaemia (ALL), remains a critical challenge in paediatric medicine. A significant proportion of patients present with ...

Leukemic ocular involvement arises from direct infiltration, hematologic derangements (anemia, thrombocytopenia, ...

Medications for AML include chemotherapy and newer targeted therapies. With several options available, the right medication for you will depend on the specific characteristics of your cancer. Acute ...

Credit: Getty Images ALL is the most common childhood cancer, and cases are rising. Find out why this trend is paired with a remarkable 90% survival rate, and what public health action is needed next.

Relapsed acute myeloid leukemia (AML) is when cancer returns after a period of remission. Refractory AML means cancer has not responded to multiple rounds of treatment. Both can affect your treatment ...

Acute lymphoblastic leukemia (ALL) may be confused with different types of hematological conditions. Confusion of ALL diagnosis with acute myeloid leukemia (AML), hairy cell leukemia and malignant ...